Currently holds positions in Dicerna Pharmaceuticals Inc and Mersana Therapeutics Inc
Position | Company | Period |
---|---|---|
Independent Director | Dicerna Pharmaceuticals Inc | Jan. 23, 2019 - |
President, Chief Executive Officer, Director | Mersana Therapeutics Inc | March 1, 2015 - |
Independent Director | Bioverativ Inc | Feb. 1, 2017 - March 8, 2018 |
Independent Director | ARIAD Pharmaceuticals Inc | April 28, 2015 - Feb. 16, 2017 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2024-01-17 | 2024-01-16 |
Mersana Therapeutics Inc
(MRSN)
|
PS Planned sale |
29,399
-19.0%
2.7179,671 USD |
29,399 -19.0% | 2.71 | 79,671 USD | |
2023-12-20 | 2023-12-18 |
Nuvalent Inc
(NUVL)
|
S Sale |
5,000
-100.0%
75.67378,350 USD |
5,000 -100.0% | 75.67 | 378,350 USD | |
2023-01-18 | 2023-01-17 |
Mersana Therapeutics Inc
(MRSN)
|
S Sale |
17,346
-26.3%
5.7499,566 USD |
17,346 -26.3% | 5.74 | 99,566 USD |